The Radiation Sources Facility provides state-of-the-art irradiation and dosimetry facilities for cancer research equal to the standards of the National Institute of Standards and Technology. This facility provides centralized radiation sources and equipment suitable for irradiating cells, tissues, or small animals. This equipment would be impractical for any individual or small group of laboratory investigators to purchase, shield, and maintain. The Radiation Sources Facility is responsible for training all users of the equipment in proper operational procedures, in keeping with the terms of the University's radiation license issued by the Nuclear Regulatory Commission. This training, conducted by the facility supervisor, includes instruction on the biological effects of ionizing radiation, radiation risk and hazard assessment, and operating procedures for the individual machines. The facility also provides dosimetry information and physics support for certified users. The supervisor of the facility is responsible for interacting with the University's Radiation Safety Committee and all regulatory agencies. This eliminates the necessity for individual investigators to deal with the regulatory bureaucracy.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014520-28
Application #
6316504
Study Section
Project Start
2000-05-30
Project End
2001-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
28
Fiscal Year
2000
Total Cost
$289,556
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Elsaid, Mohamed Y; Shahi, Ankita; Wang, Albert R et al. (2018) Enhanced Radiosensitivity in Solid Tumors using a Tumor-selective Alkyl Phospholipid Ether Analog. Mol Cancer Ther 17:2320-2328
Dennison, Kirsten L; Chack, Aaron C; Hickman, Maureen Peters et al. (2018) Ept7, a quantitative trait locus that controls estrogen-induced pituitary lactotroph hyperplasia in rat, is orthologous to a locus in humans that has been associated with numerous cancer types and common diseases. PLoS One 13:e0204727
Zaitoun, Ismail S; Cikla, Ulas; Zafer, Dila et al. (2018) Attenuation of Retinal Vascular Development in Neonatal Mice Subjected to Hypoxic-Ischemic Encephalopathy. Sci Rep 8:9166
Hart, Vicki; Trentham-Dietz, Amy; Berkman, Amy et al. (2018) The association between post-diagnosis health behaviors and long-term quality of life in survivors of ductal carcinoma in situ: a population-based longitudinal cohort study. Qual Life Res 27:1237-1247
Lee, Hye Jin; Ehlerding, Emily B; Cai, Weibo (2018) Antibody-Based Tracers for PET/SPECT Imaging of Chronic Inflammatory Diseases. Chembiochem :
Albertini, Mark R; Yang, Richard K; Ranheim, Erik A et al. (2018) Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma. Cancer Immunol Immunother 67:1647-1658
Saghiri, Mohammad Ali; Asatourian, Armen; Nguyen, Eric H et al. (2018) Hydrogel Arrays and Choroidal Neovascularization Models for Evaluation of Angiogenic Activity of Vital Pulp Therapy Biomaterials. J Endod 44:773-779
Jamali, Nasim; Sorenson, Christine M; Sheibani, Nader (2018) Vitamin D and regulation of vascular cell function. Am J Physiol Heart Circ Physiol 314:H753-H765
Liu, Zhen; Ehlerding, Emily B; Cai, Weibo et al. (2018) One-step synthesis of an 18F-labeled boron-derived methionine analog: a substitute for 11C-methionine? Eur J Nucl Med Mol Imaging 45:582-584
Chakravarty, Rubel; Siamof, Cerise M; Dash, Ashutosh et al. (2018) Targeted ?-therapy of prostate cancer using radiolabeled PSMA inhibitors: a game changer in nuclear medicine. Am J Nucl Med Mol Imaging 8:247-267

Showing the most recent 10 out of 1528 publications